We are live on ! Find out more
GP

Girard Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 17.26%
This Fund
S&P 500
This Quarter Est. Return
-5.6%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$176M
AUM Growth
-$2.47M
Cap. Flow
+$9.58M
Cap. Flow %
5.43%
Top 10 Hldgs %
24.68%
Holding
166
New
18
Increased
85
Reduced
40
Closed
15

Sector Composition

Rank Sector Weight
1 Healthcare 14.97%
2 Technology 13.25%
3 Industrials 11.48%
4 Financials 11.08%
5 Consumer Staples 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIS icon
51
Fidelity National Information Services
FIS
$21.7B
$1.21M 0.68%
17,999
-114
-0.6% -$7.59K
RAI
52
DELISTED
Reynolds American Inc
RAI
$1.21M 0.68%
27,210
-316
-1% -$13.1K
DWM icon
53
WisdomTree International Equity Fund
DWM
$665M
$1.17M 0.66%
25,821
+740
+3% +$36.5K
CVS icon
54
CVS Health
CVS
$137B
$1.15M 0.65%
+11,872
New +$1.25M
RTN
55
DELISTED
Raytheon Company
RTN
$1.12M 0.64%
10,267
-1,442
-12% -$151K
LLY icon
56
Eli Lilly
LLY
$1.05T
$1.1M 0.62%
13,107
+438
+3% +$37K
QCOM icon
57
Qualcomm
QCOM
$181B
$1.06M 0.6%
19,815
-13,657
-41% -$811K
BRK.B icon
58
Berkshire Hathaway Class B
BRK.B
$1.06T
$1.05M 0.59%
8,031
+397
+5% +$54.4K
AMGN icon
59
Amgen
AMGN
$198B
$1.04M 0.59%
7,520
+5,982
+389% +$943K
WFC icon
60
Wells Fargo
WFC
$265B
$1.03M 0.59%
20,109
+6,083
+43% +$335K
BMY icon
61
Bristol-Myers Squibb
BMY
$124B
$1.01M 0.58%
17,138
+144
+0.8% +$9.13K
CB
62
DELISTED
CHUBB CORPORATION
CB
$1.01M 0.57%
8,212
-242
-3% -$29.6K
GPC icon
63
Genuine Parts
GPC
$17.2B
$989K 0.56%
11,937
+2,780
+30% +$239K
IBM icon
64
IBM
IBM
$200B
$973K 0.55%
7,022
+2,286
+48% +$338K
CAH icon
65
Cardinal Health
CAH
$53.5B
$972K 0.55%
12,655
+2,462
+24% +$206K
KMB icon
66
Kimberly-Clark
KMB
$36B
$955K 0.54%
8,761
+847
+11% +$93.4K
CSCO icon
67
Cisco
CSCO
$441B
$933K 0.53%
35,535
+22,896
+181% +$618K
ORCL icon
68
Oracle
ORCL
$364B
$927K 0.53%
25,658
-1,714
-6% -$65.9K
CELG
69
DELISTED
Celgene Corp
CELG
$892K 0.51%
8,243
+40
+0.5% +$4.96K
XLNX
70
DELISTED
Xilinx Inc
XLNX
$882K 0.5%
20,809
-3,806
-15% -$160K
ADP icon
71
Automatic Data Processing
ADP
$102B
$873K 0.49%
10,859
+119
+1% +$9.53K
VTI icon
72
Vanguard Total Stock Market ETF
VTI
$658B
$868K 0.49%
8,797
+2,252
+34% +$236K
IWS icon
73
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$846K 0.48%
12,615
+390
+3% +$27.7K
EMR icon
74
Emerson Electric
EMR
$78.2B
$815K 0.46%
18,447
-1,395
-7% -$68.6K
COST icon
75
Costco
COST
$417B
$756K 0.43%
5,231
+665
+15% +$94.9K

Similar funds

Girard Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Girard Partners held 166 positions worth $176M, down 1.4% from $179M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Girard Partners deployed $9.58M of net new capital in Q3 2015, opening 18 new positions and adding to 85 existing holdings. Its largest new stake was CVS Health: 11,872 shares worth $1.15M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Baxter International, an estimated $1.14M trimmed.

  • Girard Partners's largest Q3 2015 buy was CVS Health: 11,872 shares worth $1.15M.
  • Girard Partners added most to Apple in Q3 2015, an estimated $956K increase.
  • Girard Partners's biggest Q3 2015 reduction was Baxter International, cutting an estimated $1.14M.
  • Girard Partners fully exited Alphabet (Google) Class C in Q3 2015, selling an estimated $2.8M.
  • Girard Partners's ten largest holdings make up 25% of its $176M portfolio in Q3 2015.
  • Girard Partners opened 18 new positions and closed 15 in Q3 2015.
  • Girard Partners's portfolio value fell 1.4% quarter-over-quarter to $176M.

Based on Girard Partners's 13F filing for Q3 2015, filed 9 Nov 2015.